Shares of health-care companies rose as traders bet the sector will benefit from the passage of a tax bill. AstraZeneca shares were in focus after analysts at brokerage Goldman Sachs said market assumptions about demand for the British drug company's product candidates were too optimistic, as reported earlier.
-Rob Curran, firstname.lastname@example.org
Continue Reading Below
(END) Dow Jones Newswires
December 13, 2017 16:22 ET (21:22 GMT)